BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 7359629)

  • 1. How to differentiate hyperparathyroid patients among intermittent hypercalcemic urinary stone formers: a combined use of immunoreactive parathyroid hormone and nephrogenous adenosine 3',5'-monophosphate.
    Kitamura T; Tanaka M; Abe K; Niijima T
    J Urol; 1980 Mar; 123(3):328-34. PubMed ID: 7359629
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrogenous cyclic AMP and plasma parathyroid hormone in hypercalcaemia: the influence of renal function.
    Bill G; Jacquet AF; Burckhardt P
    Eur J Clin Invest; 1984 Jun; 14(3):227-32. PubMed ID: 6088250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Should the parathyroid function be evaluated in a patient with calcium kidney stones? If so, when and why?].
    Gardin JP; Houillier P; Borensztein P; Paillard M
    Nephrologie; 1991; 12(2):71-7. PubMed ID: 1944759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normocalcemic hyperparathyroidism with "normal" parathyroid glands.
    Shieber W; Birge SJ; Avioli LV; Teitelbaum SL
    Arch Surg; 1971 Aug; 103(2):299-302. PubMed ID: 5562816
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypercalciuria and primary hyperparathyroidism in patients with kidney calculi. II. Primary hyperparathyroidism].
    Nieszporek T; Kokot F; Skrzypek J; Wieczorek M; Kuska J
    Pol Arch Med Wewn; 1992 Jan; 87(1):49-53. PubMed ID: 1641364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperparathyroidism with asymptomatic hypercalcemia.
    Amorosa LF; Amorosa JK
    Hosp Pract (Off Ed); 1983 Sep; 18(9):223, 227, 232-4 passim. PubMed ID: 6411594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathogenesis of idiopathic hypercalciuria: evidence for parathyroid hyperfunction.
    Evans RA; Hills E; Wong SY; Wyndham LE; Eade Y; Dunstan CR
    Q J Med; 1984; 53(209):41-53. PubMed ID: 6324269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cyclic adenosine monophosphate: an accurate index of parathyroid function.
    Drezner MK; Neelon FA; Curtis HB; Lebovitz HE
    Metabolism; 1976 Oct; 25(10):1103-12. PubMed ID: 184364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possibility of elevated parathyroid function in patients with calcium-containing nephrolithiasis as compared with normal controls.
    Kitamura T; Hirano Y; Ueda D; Niijima T
    Eur Urol; 1987; 13(1-2):90-9. PubMed ID: 3034619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary hyperparathyroidism and nephrolithiasis].
    Tiktinskiĭ OL
    Sov Med; 1978 Oct; (10):99-104. PubMed ID: 362554
    [No Abstract]   [Full Text] [Related]  

  • 11. A spot sample test for the estimation of urinary or nephrogenous cAMP in the evaluation of parathyroid function.
    Kraiem Z; Glaser B; Rosenzweig A; Sheinfeld M; Ben-Ari J
    Nephron; 1983; 35(4):264-6. PubMed ID: 6316183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe hypercalcemic hyperparathyroidism developing in a patient with hyperaldosteronism and renal resistance to parathyroid hormone.
    Park-Sigal J; Don BR; Porzig A; Recker R; Griswold V; Sebastian A; Duh QY; Portale AA; Shoback D; Schambelan M
    J Bone Miner Res; 2013 Mar; 28(3):700-8. PubMed ID: 23074096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria.
    Pak CY; Oata M; Lawrence EC; Snyder W
    J Clin Invest; 1974 Aug; 54(2):387-400. PubMed ID: 4367891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory tests in the diagnosis of hyperparathyroidism in hypercalcemic patients.
    Strott CA; Nugent CA
    Ann Intern Med; 1968 Jan; 68(1):188-202. PubMed ID: 5635317
    [No Abstract]   [Full Text] [Related]  

  • 15. Ionised calcium levels in "normocalcaemic" hyperparathyroidism.
    Muldowney FP; Freaney R; Spillane EA; O'Donohoe P
    Ir J Med Sci; 1973 Sep; 142(5):223-9. PubMed ID: 4755426
    [No Abstract]   [Full Text] [Related]  

  • 16. Response to an oral calcium load in nephrolithiasis patients with fluctuating parathyroid hormone and ionized calcium levels.
    Gomes SA; Lage A; Lazaretti-Castro M; Vieira JG; Heilberg IP
    Braz J Med Biol Res; 2004 Sep; 37(9):1379-88. PubMed ID: 15334204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrolithiasis and hyperparathyroidism.
    Broadus AE
    Hosp Pract (Off Ed); 1982 Jan; 17(1):98A, 98G-98H, 98L passim. PubMed ID: 6818128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney stones as a manifestation of hypercalcemic disorders. Hyperparathyroidism and sarcoidosis.
    Rodman JS; Mahler RJ
    Urol Clin North Am; 2000 May; 27(2):275-85, viii. PubMed ID: 10778470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperparathyroidism.
    Goldsmith RS
    N Engl J Med; 1969 Aug; 281(7):367-74. PubMed ID: 4893704
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis and treatment of hyperparathyroidism].
    Mikhaĭlov IuM
    Sov Med; 1979 Jun; (6):96-101. PubMed ID: 472887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.